Global disease prevalence: Anal cancer is a rare malignant tumor worldwide; while incidence is higher in specific populations, it affects slightly more women than men.
Staging-based treatment for anal cancer
Early treatment (involving a localized, small tumor with a favorable response)
specifically combined radiotherapy and chemotherapy—can effectively control tumor progression while preserving anal function, and the patient's prognosis is relatively good.
Intermediate-stage treatment (addressing local spread, inhibiting growth, and delaying progression)
employs a comprehensive approach—combining chemoradiotherapy with surgery—to control further tumor spread while preserving anal function to the greatest extent possible.
Treatment for advanced-stage disease (involving distant metastasis, symptom relief, and survival prolongation)
primarily relies on systemic therapies such as radiotherapy and chemotherapy to alleviate clinical symptoms and extend patient survival as much as possible.
Consequences of failing to receive timely treatment in the early stage: If standardized treatment is not administered promptly in the early stage, the tumor will continue to grow and spread/metastasize to surrounding tissues and distant lymph nodes, resulting in a missed opportunity for optimal intervention.
Why choose Fosun Health for anal cancer treatment
Fosun Health’s anal cancer diagnosis and treatment services are managed by the specialized center for gastrointestinal tumors. The team possesses extensive experience in sphincter-sparing concurrent chemoradiotherapy, local excision, and comprehensive treatment for advanced-stage disease.Leveraging a global medical network, patients have access to state-of-the-art international treatments such as local excision, concurrent chemoradiotherapy (5-FU/mitomycin plus radiotherapy), CyberKnife M6 precision radiotherapy, targeted therapy, and immunotherapy.
For complex cases such as advanced or recurrent anal cancer, a multidisciplinary team (MDT)—comprising experts in colorectal surgery, radiation oncology, medical oncology, and radiology—collaborates to formulate the optimal treatment plan; a cross-border consultation mechanism enables patients to obtain second opinions from leading international centers.
Foshan Fosun Chancheng Hospital is equipped with the CyberKnife M6 precision radiotherapy system and the VitalBeam linear accelerator, enabling the delivery of precision intensity-modulated radiotherapy (IMRT) and stereotactic radiosurgery (SRS).The hospital has extensive experience in anal-sparing treatments for anal cancer, utilizing concurrent chemoradiotherapy combined with precision radiotherapy to maximize functional preservation while enhancing therapeutic efficacy, thereby offering personalized, comprehensive care for patients at different stages of the disease.
Anal Cancer Treatment Methods
1.VitalBeam linear accelerator precision radiotherapy
For most non-metastatic squamous cell carcinomas of the anal canal, radiotherapy is typically administered concurrently with chemotherapy; a precise radiotherapy plan can be formulated based on tumor size, extent of invasion, and regional lymph node status.
Treatment advantages:
① Organ preservation: Some patients can avoid radical surgery—which would necessitate a permanent colostomy—through concurrent chemoradiotherapy.
② Precision irradiation: Capable of simultaneously covering the primary tumor and regional lymphatic drainage areas.
③ Dose optimization: Formulates an individualized dose distribution based on tumor extent and surrounding normal tissues.
④ Combination therapy: May be used in combination with concurrent chemotherapy for certain cases of non-metastatic squamous cell carcinoma of the anal canal.
2.Local surgical resection
Local excision may be considered for certain small, well-situated, and localized perianal or anal canal lesions; surgery may also be evaluated on a case-by-case basis for patients with residual disease or recurrence following concurrent chemoradiotherapy.
Treatment advantages:
① Direct resection: Localized tumor lesions can be removed.
② Obtain pathology: Resected tissue allows for further clarification of tumor characteristics and margin status.
③ Local therapy: Therapeutically valuable for select early-stage, localized lesions.
④ Salvage therapy: Can serve as a further treatment modality for select cases of local recurrence or residual lesions following radiotherapy or chemotherapy.
3. Abdominoperineal resection
For patients with persistent local disease or local recurrence following chemoradiotherapy that cannot be controlled by local excision, abdominoperineal resection may be considered after evaluating the extent of the lesion and the patient's overall condition.
Treatment advantages:
① Extended resection: Allows for the removal of tumors and affected tissues that cannot be controlled via local surgery.
② Local control: Suitable for certain persistent or recurrent localized lesions.
③ Clarify pathology: Resected specimens allow for comprehensive pathological assessment.
④ Salvage therapy: Can serve as a salvage surgical option for select patients who have failed local therapy.
4.Chemotherapy
Kills cancer cells using anticancer drugs such as mitomycin; often combined with radiotherapy to enhance efficacy and control distant metastasis.
5.Immunotherapy
Activates the body's immune system to recognize and attack cancer cells, providing a new, effective treatment option for patients with advanced anal cancer to improve therapeutic efficacy.
6.Targeted therapy
Delivers precision strikes against specific molecular targets; offers good efficacy with relatively mild side effects; suitable for select patients with advanced-stage disease.Helps improve therapeutic outcomes.
7.Comprehensive therapy
Formulate an individualized comprehensive treatment plan based on the patient's specific condition, combining modalities such as radiotherapy, chemotherapy, and surgery to enhance therapeutic efficacy.
8.Supportive care
Approaches such as nutritional support, psychological counseling, and symptom management can comprehensively improve the patient's physical condition and quality of life.
Post-treatment care
Maintain anal hygiene and a high-fiber diet; avoid prolonged sitting and constipation; attend scheduled follow-up appointments and actively cooperate with subsequent treatment as advised.
Post-treatment examinations
Regular digital rectal examinations, tumor marker testing, and follow-up imaging are required after treatment to detect changes in the condition in a timely manner.
Conclusion
Anal cancer poses a serious threat; successful treatment hinges on early detection, diagnosis, and intervention, as well as selecting the appropriate treatment plan and adhering to follow-up care, which helps improve quality of life.
